Literature DB >> 11343243

Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.

H A Järveläinen1, A Orpana, M Perola, V T Savolainen, P J Karhunen, K O Lindros.   

Abstract

Twin concordance studies indicate that genetic factors influence the individual susceptibility for alcoholic liver disease (ALD). Both clinical and experimental data suggest that Kupffer cell activation by gut-derived endotoxins and other bacterial products is an important pathogenic factor. Activated Kupffer cells release proinflammatory cytokines, a process that is regulated by the CD14 endotoxin receptor (CD14). Recently, a C-->T (-159) polymorphism in the promoter region of the CD14 gene was detected and found to confer increased CD14 expression. In the present study, the association of CD14 promoter polymorphism with different forms of ALD was examined in 3 separate autopsy series. Among 442 men with valid alcohol-consumption data, 381 men had been moderate or heavy alcohol consumers. The allele frequency of the CD14 promoter genotype, determined by a modified cycle minisequencing technique, was 0.34 (CC), 0.51 (CT), and 0.16 (TT). The T allele was found to be associated with advanced ALD, i.e., with alcoholic hepatitis (odds ratio [OR]: 2.48; P = .018), and especially with cirrhosis (OR: 3.45; P = .004), but not with fatty liver, periportal fibrosis, or bridging fibrosis. The overall age-adjusted risk for cirrhosis was 3.08 (P = .01) for the carriers of the CT genotype, and 4.17 (P = .005) for the homozygous TT genotype. These results suggest that in the relatively isolated Finnish population, the T allele confers increased risk of alcoholic liver damage. In particular, TT homozygotes are at a high risk to develop cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343243     DOI: 10.1053/jhep.2001.24236

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

1.  Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.

Authors:  P Brun; I Castagliuolo; A R Floreani; A Buda; L Blasone; G Palù; D Martines
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Association of promoter polymorphism of the CD14 C (-159) T endotoxin receptor gene with chronic hepatitis B.

Authors:  Amir Houshang Mohammad Alizadeh; Mitra Ranjbar; Mehrdad Hajilooi; Farahnaz Fallahian
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

3.  Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection.

Authors:  Eva Askar; Giuliano Ramadori; Sabine Mihm
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

4.  Alcoholic Liver Disease in Asia, Europe, and North America.

Authors:  Suthat Liangpunsakul; Paul Haber; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

5.  CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.

Authors:  You-Chen Chao; Heng-Cheng Chu; Wei-Kuo Chang; Hsin-Hung Huang; Tsai-Yuan Hsieh
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

6.  Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.

Authors:  C Meiler; M Muhlbauer; M Johann; A Hartmann; B Schnabl; N Wodarz; G Schmitz; J Scholmerich; C Hellerbrand
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 7.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

Review 8.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

Review 9.  Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.

Authors:  Eric S Orman; Gemma Odena; Ramon Bataller
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

10.  Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity.

Authors:  Jasmin Mertens; Rusudan Bregadze; Ashham Mansur; Eva Askar; Heike Bickeböller; Giuliano Ramadori; Sabine Mihm
Journal:  J Mol Med (Berl)       Date:  2009-05-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.